Percutaneous absorption preparation for treating dementia comprising donepezil
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 28, 2024
Grant Date -
Mar 4, 2021
app pub date -
Nov 7, 2018
filing date -
Dec 27, 2017
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A percutaneous absorption preparation is disclosed. The percutaneous absorption preparation contains donepezil for treatment of dementia, wherein the preparation includes: (a) donepezil or its pharmaceutically acceptable salt as active component, (b) propylene glycol monocaprylate as solubilizer, and (c) styrene-isoprene-styrene block copolymer (“SIS”) as adhesive. The percutaneous absorption preparation has low skin irritation and high skin penetration.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully